316 related articles for article (PubMed ID: 22199005)
1. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease.
Hayashi M; Takayanagi N; Kanauchi T; Miyahara Y; Yanagisawa T; Sugita Y
Am J Respir Crit Care Med; 2012 Mar; 185(5):575-83. PubMed ID: 22199005
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and radiographic outcomes of nontuberculous mycobacterial lung disease in rheumatoid arthritis.
Yamakawa H; Takayanagi N; Miyahara Y; Ishiguro T; Kanauchi T; Hoshi T; Yanagisawa T; Sugita Y
J Rheumatol; 2013 Aug; 40(8):1307-15. PubMed ID: 23588941
[TBL] [Abstract][Full Text] [Related]
4. Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression.
Pan SW; Shu CC; Feng JY; Wang JY; Chan YJ; Yu CJ; Su WJ
Clin Infect Dis; 2017 Sep; 65(6):927-934. PubMed ID: 28541556
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
Ramirez J; Mason C; Ali J; Lopez FA
J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
[TBL] [Abstract][Full Text] [Related]
7. Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors.
Bamba Y; Moro H; Aoki N; Koizumi T; Ohshima Y; Watanabe S; Sakagami T; Koya T; Takada T; Kikuchi T
BMC Infect Dis; 2019 Mar; 19(1):263. PubMed ID: 30885152
[TBL] [Abstract][Full Text] [Related]
8. Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
Shirai T; Furuuchi K; Fujiwara K; Nakamoto K; Tanaka Y; Ishii H; Yoshiyama T; Yoshimori K; Takizawa H; Sasaki Y; Kurashima A; Ohta K; Morimoto K
Respir Med; 2020 May; 166():105955. PubMed ID: 32321630
[TBL] [Abstract][Full Text] [Related]
9. Natural history of
Hwang JA; Kim S; Jo KW; Shim TS
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28275170
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study.
Kumagai S; Ito A; Hashimoto T; Marumo S; Tokumasu H; Kotani A; Yamaki H; Shirata M; Furuuchi K; Fukui M; Ishida T
BMC Infect Dis; 2017 Jun; 17(1):436. PubMed ID: 28629426
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease.
Furuuchi K; Ito A; Hashimoto T; Kumagai S; Ishida T
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):91-98. PubMed ID: 28920166
[TBL] [Abstract][Full Text] [Related]
13. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.
Lee BY; Kim S; Hong Y; Lee SD; Kim WS; Kim DS; Shim TS; Jo KW
Antimicrob Agents Chemother; 2015; 59(6):2972-7. PubMed ID: 25753634
[TBL] [Abstract][Full Text] [Related]
15. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
16. Impact of prognostic nutritional index on outcomes in patients with Mycobacterium avium complex pulmonary disease.
Moon SW; Lee EH; Choi JS; Leem AY; Lee SH; Lee SH; Kim SY; Chung KS; Jung JY; Park MS; Kim YS; Kang YA
PLoS One; 2020; 15(5):e0232714. PubMed ID: 32374770
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Mycobacterium avium Complex (MAC).
Griffith DE
Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
[No Abstract] [Full Text] [Related]
18. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
[TBL] [Abstract][Full Text] [Related]
19. Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.
Chae G; Park YE; Chong YP; Lee HJ; Shim TS; Jo KW
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0226121. PubMed ID: 35950842
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease.
Koh WJ; Jeong BH; Jeon K; Lee NY; Lee KS; Woo SY; Shin SJ; Kwon OJ
Chest; 2012 Dec; 142(6):1482-1488. PubMed ID: 22628488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
